stroke
The higher rate of stroke in women after treatment with alteplase (2.0% vs 1.9% with streptokinase and intravenous heparin) was offset by a greater relative reduction in mortality (10.3% vs 11.1%).
The higher rate of <span class="disease" id="8598594-13-19-25">stroke</span> in women after treatment with <span class="gene" id="8598594-13-56-65">alteplase</span> (2.0% vs 1.9% with streptokinase and intravenous heparin) was offset by a greater relative reduction in mortality (10.3% vs 11.1%).